Week 3 of being on a GLP1

Starting a GLP-1 (Glucagon-Like Peptide-1) therapy can often bring about intense changes, especially around the third week as your body adjusts. From my own experience, during week 3, I noticed symptoms such as nausea, occasional headaches, and fluctuations in appetite became more pronounced. These effects, while challenging, are common as GLP-1 mimetics work to regulate blood sugar and reduce appetite. One useful strategy I found was staying well-hydrated and eating smaller, more frequent meals to ease nausea. Additionally, engaging in light physical activity helped me maintain energy and mood. It’s important to communicate with your healthcare provider if symptoms intensify or persist, as dosage adjustments may be needed. Another aspect worth mentioning is the psychological adjustment; the changes in hunger and eating habits can be mentally taxing. Joining support communities online where others share their GLP-1 experiences provided me with emotional encouragement and practical tips on symptom management. Overall, week 3 is a critical phase where your body is adapting to GLP-1 therapy’s effects. Patience and careful self-monitoring can make this period more manageable. Remember, every individual’s response varies, so personalized care is key to optimizing benefits from GLP-1 treatment.